Mark your calendars: Padres Pedal the Cause is back

After a brief slowdown, Padres Pedal the Cause is ready to ride again.

New COVID-19 drug passes phase 2 clinical trial

The new treatment, developed by Avalo Therapeutics with Sanford Burnham Prebys researchers, can mitigate lung damage and improve survival in COVID patients.

Sanford Burnham Prebys researchers awarded $3.6 million to study antibiotic resistance

The five-year project will utilize an “evolution machine” to shed new light on how bacteria develop antibiotic resistance.